期刊文献+

2型糖尿病周围神经病变与C肽水平的相关性研究 被引量:6

Relationship between type 2 diabetic peripheral neuropathy and C-peptide level
下载PDF
导出
摘要 目的了解住院2型糖尿病患者周围神经病变的患病率,探讨C肽与DPN的相关关系,研究DPN的危险因素。方法根据是否合并DPN将211例T2DM患者分为3组:单纯2型糖尿病组(T2DM组,n=44)与T2DM合并轻度周围神经病变组(轻度病变组,n=89),中、重度周围神经病变组(中重度病变组,n=78)。结果住院T2DM患者DPN的患病率为79.14%,总神经病变组(轻度+中重度病变组)年龄、病程、HbA1C、PBG、吸烟等水平显著高于T2DM组,差异有统计学意义(P<0.05)。空腹C肽、糖负荷2hC肽水平均显著低于T2DM组,差异有统计学意义(P<0.01)。DPN与年龄、病程、BMI、HbA1C成正相关(P<0.05),与2hC肽成负相关(P<0.05)。年龄、病程、吸烟、HbA1C是DPN的独立危险因素,2hC肽为保护因素。结论住院的T2DM患者DPN患病率较高,糖负荷2hC肽水平与T2DM发生DPN密切相关,C肽对周围神经具有保护作用。 Objective To understand the incidence of hospitalized patients with type 2 diabetic peripheral neuropathy, investigate the relationship between type 2 diabetic peripheral neuropathy and C-peptide level, and analyze the risk factors of I)PN. Methods The patients were divided into three groups: type 2 diabetes mellitus group (T2DM group, n=44 ), type 2 diabetes mellitus and mild peripheral neuropathy group (mild group, n=89 ), type 2 diabetes mellitus and severe peripheral neuropathy group (severe group,n=78 ). Results The prevalence of DPN in hospitalized diabetic patients was 79.14% .Total peripheral neuropathy group's age, duration, HbA1C, PBG, smoking levels were higher than the T2DM group (P 〈 0.05 ). Fasting C-peptide, glucose load 2 h C-peptide levels were significantly lower than the T2DM group (P 〈 0.01 ).Age, duration, smoking, HbA1C were independently risk factors of peripheral neuropathy in type 2 diabetic patients, glucose load 2 h C- peptide was negatively correlated(P 〈 0.05 ). Conclusion The prevalence of DPN in hospitalized diabetic patients is high. T2DM complicated by DPN is closely related to glucose load 2 h C-peptide level. C-peptide has a protective effect on peripheral nerve.
出处 《中国医药科学》 2013年第4期20-21,26,共3页 China Medicine And Pharmacy
关键词 2型糖尿病 糖尿病周围神经病变 C肽 Type 2 diabetes Peripheral neuropathy C-peptide
  • 相关文献

参考文献9

  • 1Cameron N E, Cotter M A.Pro-inflammatory mechanisms in diabetic neuropathy:focus on the nuclear factor kappa B pathway[J].Curr Drug Targets, 2008,9 : 60-67.
  • 2Karin E, Tom B, Bo-Lennart J, et aL.C-peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy[J].Diabetes Care,2007, 30: 71-76.
  • 3Morkrid K, Ali L, Hussain A.Risk factors and prevalence of diabetic peripheral neuropathy:A study of type 2 diabetic outpatients in Bangladesh[J].Int J Diabetes Dev Ctries, 2010, 30 ( 1 ) : 11-17.
  • 4Lu B, Yang Z, Wang M, et al.High prevalence of diabetic neuropathy in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown[J].Diabetes Res Clin Pract,2010,88 ( 3 ) : 89-94.
  • 5李菁爽,詹晓蓉,阴慧清.C肽对糖尿病大鼠坐骨神经结构和功能的影响[J].现代生物医学进展,2006,6(11):9-10. 被引量:4
  • 6Ekberg K, Brismar T, Johansson BI, et al.Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes[J].Diabetes, 2003,52: 536-541.
  • 7Kamiya H, Zhang W, Ekberg K, et al.C-peptide reverses nociceptive neuropathy in type 1 diabetes [J].Diabetes,2006,55 ( 12 ) : 3581-3587.
  • 8Sima AAF, Zhang W, Sugimoto K, et al.C-pepfide prevents and improves chronic type 1 diabetic polyneuropathy in the BB/Wor rat[J].Diabetdogia, 2001,449 ( 7 ) : 889-897.
  • 9Daniela M, Emilia R, Angela MA, et al.Residual C-peptide secretion and endothelial function in patients with type 2 diabetes[J].Clinical Science, 2003,105 ( 1 ): 113-118.

二级参考文献8

  • 1Forst T,Kunt T.Effect of C-peptide on microvascular blood flow and blood hemorheology[J].Exp Diabesity Res,2004,5(1):51-64
  • 2Tsimaratos M,Roger F,Chabardes D,et al.C-peptide stimulates Na-K-ATPase activity via PKC alpha in rat medullay thick ascending limb[J].Diabetologia,2003,46:124-131
  • 3Ekberg K,Boris mar T,Johansson BL,et al.Amelioration of Sensory Nerve Dysfunction by C-peptide in Patients With Type 1 Diabetes[J].Diabetes,2003,52:536-541
  • 4Cotter MA,Ekberg K,Wahren J,et al.Effects ofproinsulin C-peptide in experimental diabetic neuropathy:vascular actions and modulation by nitric oxide synthase inhibition[J].Diabetes,2003,52:536-541
  • 5Johansson BL,Borg K,Fernqvist-Forbes E.Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type Ⅰ diabetes mellitus[J].Diabet Med,2000,17:181-189
  • 6Samnegard B,Jacobson SH,Jarmko G,et al.Effects of C-peptide on glomerular and renal size and renal function in diabetic rats[J].Kidney Int,2001,60 (4):1258-1265
  • 7Samnegard B,Jacobson SH,Jaremko G,et al.C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats[J].Nephrol Dial Transplant,2005,20(3):532-538
  • 8Forst T,Dufayet D,Kunt T,et al.Effects of proinsul in C-peptide on nitric oxide,crovascular blood flow and erythrocyte Na+2K+2ATPase activity in diabetes mellitus type l[J].Clin Sci,2000,98(3):283-290

共引文献3

同被引文献58

  • 1Otto-Buczkowska E,Kazibutowska Z,Sofiyk J,et al.Neuropathy and type 1 diabetes mouitus[J].Pediair Endocrinol Diabetes Metab, 2008,14(2): 109-116.
  • 2Papanas N,Giassakis G,Papatheodorou K,et al. Use of the new indi-cator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients[J].Exp Clin Endocrinol Dia- betes, 2007,115 ( 1): 58-61.
  • 3Papanas N, Boulton AJ, Malik RA,et al.A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy [J].Dia- bet Med, 2013,30(5):525-534. doi: 10.1111/dme. 12000.
  • 4Tentolouris N,Vonlgari C,Liatis S,et al.Moisture status of the skin of the feet assessed by the visual test neuropad correlates with foot ul- ceration in diabetes[J].Diabetes Care, 2010, 33(5): 1112-1114. doi: 10.2337/dc09-2027.
  • 5Ekberg K,Brismar T,Johansson B,et al.C-Peptide replacement thera- py and sensory nerve function in type 1 diabetic neuropathy [J].Dia- betes Care, 2007,30(1):71-76.
  • 6Bo S,Gentile L, Castiglione A,et al.C-peptide and the risk for inci- dent complications and mortality in type 2 diabetic patients: a retro- spective cohort study after a 14-year follow-up[J].Eur J Endocrinol, 2012,167(2):173-180.doi: 10.1530/EJE-12-0085.
  • 7夏威,张菱,文世林.α-硫辛酸治疗老年2型糖尿病周围神经病变的观察[J].中国误诊学杂志,2008,8(24):5867-5868. 被引量:12
  • 8夏朝霞,郭有学,汪代杰,彭艳.甲钴胺对2型糖尿病周围神经病变的治疗作用[J].西部医学,2008,20(6):1219-1220. 被引量:14
  • 9马驰骋,李振作,刘平丽,张慧明.α-硫辛酸治疗2型糖尿病周围神经病变[J].临床医学,2008,28(11):12-14. 被引量:9
  • 10马晓昀,徐格致.无糖尿病视网膜病变表现的糖尿病患者视网膜神经纤维层厚度的研究(英文)[J].复旦学报(医学版),2009,36(3):270-275. 被引量:8

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部